REFERENCES
- Adams RD, Kubik CS. The morbid anatomy of the demyelinative disease. Am] Med 1952; 12: 510–546
- Mandler RN, Davis LE, Jeffery DR, et al. Devic's neuromyelitis optica: A clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162–168
- Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450–1461
- de Seze J, Lebrun C, Stojkovic T, et al. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003; 9: 521–525
- O'Riorda nil, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996; 60: 382–387
- Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: Clinical predictors of a relapsing course and survival. Neurology 2003; 60: 48-53
- Katz JD, Ropper AH. Progressive necrotic myelopathy: Clinical course in 9 patients. Arch Neurol 2000; 57: 355–361
- Fukazawa T, Kikuchi S, Miyagishi R, et al. CSF pleocytosis and expansion of spinal lesions in Japanese multiple sclerosis with special reference to the new diagnostic criteria. J Neurol 2005; 252: 824–829
- Lennon VA, Wingerchuk DM, Kryzer TJ, et al. Serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112